2021
Reward drinking and naltrexone treatment response among young adult heavy drinkers
Roos CR, Bold KW, Witkiewitz K, Leeman RF, DeMartini KS, Fucito LM, Corbin WR, Mann K, Kranzler HR, O'Malley SS. Reward drinking and naltrexone treatment response among young adult heavy drinkers. Addiction 2021, 116: 2360-2371. PMID: 33620746, PMCID: PMC8328878, DOI: 10.1111/add.15453.Peer-Reviewed Original Research
2015
An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate
Gueorguieva R, Wu R, Tsai WM, O’Connor P, Fucito L, Zhang H, O’Malley S. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate. European Neuropsychopharmacology 2015, 25: 1586-1599. PMID: 26141511, PMCID: PMC4600651, DOI: 10.1016/j.euroneuro.2015.06.006.Peer-Reviewed Original ResearchConceptsAcamprosate effectHeavy drinkingShort abstinenceEnhanced treatment responseMonths of treatmentSubgroup of patientsBody mass indexDrug plasma levelsIdentification of subgroupsBetter prognosisLower BMIMass indexPlasma levelsGlutamatergic hyperactivityTreatment responseAcamprosateCOMBINE StudyPrior treatmentLarger studyConsecutive daysAbstinencePretreatment abstinenceTreatment effectsCognitive inefficiencySubgroups
2014
Smokers’ Treatment Expectancies Predict Smoking Cessation Success
Fucito LM, Toll BA, Roos CR, King AC. Smokers’ Treatment Expectancies Predict Smoking Cessation Success. The Journal Of Smoking Cessation 2014, 11: 143-149. PMID: 27594921, PMCID: PMC5006744, DOI: 10.1017/jsc.2014.17.Peer-Reviewed Original ResearchTreatment expectanciesQuit ratesPlacebo-controlled trialSmoking cessation successBetter treatment responseSmoking cessation aidSmoking cessation outcomesHigher quit ratesLower quit ratesNaltrexone groupPlacebo groupQuit dateCessation treatmentNicotine patchCessation aidCessation successCigarette smokersParticular medicationCessation outcomesTreatment responseBehavioral counselingMedication experienceTreatment assignmentFirst monthSmokers
2012
Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence
Fucito LM, Park A, Gulliver SB, Mattson ME, Gueorguieva RV, O'Malley SS. Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence. Biological Psychiatry 2012, 72: 832-838. PMID: 22541040, PMCID: PMC3410039, DOI: 10.1016/j.biopsych.2012.03.023.Peer-Reviewed Original ResearchConceptsCigarette smokingAlcohol dependenceBehavioral interventionsAlcohol-dependent smokersCombination of medicationsBaseline demographic differencesPoor treatment outcomesPoor treatment responseDrinking outcomesBetter drinking outcomesSevere alcohol dependenceAlcohol-dependent individualsCigarette intakeAlcohol use outcomesMedical managementPharmacological treatmentTreatment outcomesTreatment responseSmokingSmokersCOMBINE StudyAlcoholism typologyDrinking-related variablesTreatment assignmentNonsmokers
2009
Beliefs and Attitudes About Bupropion: Implications for Medication Adherence and Smoking Cessation Treatment
Fucito LM, Toll BA, Salovey P, O’Malley S. Beliefs and Attitudes About Bupropion: Implications for Medication Adherence and Smoking Cessation Treatment. Psychology Of Addictive Behaviors 2009, 23: 373-379. PMID: 19586156, PMCID: PMC3094849, DOI: 10.1037/a0015695.Peer-Reviewed Original ResearchConceptsPositive beliefsDisadvantages of smokingRole of beliefsTreatment adherenceSmoking cessation treatmentSmoking lapseSmoking cessation trialPreliminary supportCessation outcomesPositive attitudesCessation treatmentBetter treatment adherenceCessation trialBeliefsAttitudesMedication adherenceBupropion therapyBetter treatment responseGreater medication adherenceSecondary analysisMotivationTreatment responseIntentionBupropionLapse